Warning letterFDA · Apr 29, 2026
Named company: OptiHealth Products, Inc.
This can decrease the risk of cardiovascular diseases, which are a major health concern for aging populations.” This post links to the following blog on the firm’s website “Seeing Clearly: Combating Oxidative…
Warning letterFDA · Apr 24, 2026
Named company: Ray’s Vitamins
Based on our review, this product is an unapproved new drug under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a). Furthermore, your “Yeicob Ácido Hialurónico” product…
Warning letterFDA · Apr 24, 2026
Named company: ibeautistore.com
The samples of your “New Hyaluronic Acid 850 mg Sealed 30 Caps” product were labeled as “Umary.” As such, this product will be hereinafter referred to as “Umary.” 1 Based on our review, this product is an…
Warning letterFDA · Apr 15, 2026
Named company: JW Nutritional LLC
This warning letter summarizes significant violations of Current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals. Because your methods, facilities, or controls for manufacturing,…
Import alertFDA · Apr 15, 2026
Named company: Vanity Vision
DETENTION WITHOUT PHYSICAL EXAMINATION OF DIETARY SUPPLEMENT PRODUCTS FROM FIRMS THAT HAVE NOT MET DIETARY SUPPLEMENT GMP. Firm/address: Vanity Vision Date Published : 04/15/2026 S - 14 - 09 Sector 75 ,…
Recall noticeFDA · Apr 10, 2026
Named company: Blueroot Health
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. More Recalls, Market…
Warning letterFDA · Apr 7, 2026
Named company: Nature’s Elements, Inc.
Based on inspectional findings and review of the product labels collected during the inspection, as well as review of your website www.natureselements.net, we have identified significant violations of the…
Public notificationFDA · Apr 3, 2026
Named company: ZMB Enterprises, LLC
Contains Phenibut (β-phenyl-GABA) and undeclared 1,4-DMAA (1,4-dimethylamylamine)
Recall noticeFDA · Apr 1, 2026
Named company: Aphreseller
When a company announces a recall, market withdrawal, or safety alert, the FDA posts the company's announcement as a public service. FDA does not endorse either the product or the company. More Recalls, Market…
Warning letterFDA · Mar 31, 2026
Named company: Prime Sciences
Based on our review, these products are unapproved new drugs under section 505(a) of the Federal Food, Drug, and Cosmetic Act (FD&C Act), 21 U.S.C. 355(a). These products are especially concerning from a…